Home > News
|
Clinical Trials Update: Apr. 7, 2004 |
|
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication for the treatment of androgen-independent prostate cancer (AIPC). Male volunteers 18 or older who have been diagnosed with adenocarcinoma of the prostate with evidence of metastatic disease including either of the following: lymph node metastasis measurable by CT and/or bone metastasis evaluable by bone scan and who have been vaccinated against smallpox may be eligible. Research sites located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat36.html.
-----
A research study of an investigational medication for the treatment of Crohn's disease. Volunteers age 18 or older who have been diagnosed with Crohn's disease for at least six months and who have never taken natalizumab may be eligible. Research sites located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat51.html.
-----
A research study to evaluate the effects of a marketed anti-seizure drug on the sleep cycles of adults with partial onset epilepsy. Volunteers age 18-45 who have partial onset epilepsy and have been taking a stable dose of carbamazepine (Tegretol) or phenytoin (Dilantin) for four weeks prior to study participation may be eligible. Research sites located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat62.html.
-----
Copyright 2004 CenterWatch. All rights reserved.
Copyright © 2004 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder® does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder® health library.
